DKSH has signed a strategic business partnership with Kyowa Kirin, a Japan-based global specialty ... Singapore, Thailand, Malaysia and Hong Kong & Macau SAR. With DKSH's expertise, distribution ...

Kyowa Kirin will optimize Asia-Pacific (APAC) operations and maximize the value of the company's Global and Established Brands for patients in APAC. Kyowa Kirin has agreed to enter into strategic ...

Kyowa Kirin to expand manufacturing footprint with ... commercial rights to seven established brands in South Korea, Malaysia, Thailand, Hong Kong, Macau and Taiwan. Under that deal, DKSH gets ...

TOKYO and LONDON and BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a Japan-based global specialty pharmaceutical company (J-GSP) creating innovative ...

LONDON — The Japanese firm Kyowa Kirin is acquiring gene therapy maker Orchard Therapeutics in a $400 million deal, the companies said Thursday. Kyowa Kirin is paying $16 per share — a nearly ...

Kyowa Kirin Co., Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous ...

Kyowa Kirin shares are viewed as a cheap option on the positive outcome for the atopic dermatitis drug being developed with Amgen. The company's recent track record for new drug trial success has ...

You can reach Adam on Signal at stataf.54. Kura Oncology has signed a global partnership with the Japanese drugmaker Kyowa Kirin to develop and sell Kura’s experimental treatment for acute ...

View today's Kyowa Kirin Co Ltd stock price and latest 4151 news and analysis. Create real-time notifications to follow any changes in the live stock price.

TOKYO, Oct 5 (Reuters) - Japanese pharmaceutical firm Kyowa Kirin (4151.T), opens new tab said on Thursday it would acquire Britain-based biopharmaceutical company Orchard Therapeutics for $477.6 ...